Follicular lymphoma is an indolent malignancy with a generally favorable prognosis, with survival often measured in decades. Yet up to 20% of patients develop early progression after starting ...
Comparing Hodgkin and Non-Hodgkin Lymphoma Mortality Between Latin America and the United States From 2008 to 2019: The Need of Regional-Based Lymphoma Registries Hodgkin lymphoma (HL) is classified ...
Messaging that foregrounds worst-case cancer outcomes can distort expectations, obscuring that modern therapies often aim to preserve function and extend meaningful survival. A chronic, “incurable” ...